From The Economic Times · Reghu Balakrishnan · · 1m
Ichor Biologics seeks $80-100M PE funding for minority stake
Hyderabad biotech firm aims to raise $80-100 million from private equity to expand plasma therapy operations
In brief
Hyderabad biotech firm aims to raise $80-100 million from private equity to expand plasma therapy operations Ichor Biologics needs $80-100 million from private equity to scale its plasma therapy production capacity Originally reported by The Economic Times.
Ichor Biologics funding round
Hyderabad-based Ichor Biologics seeks $80-100 million from private equity investors for a minority stake sale
Plasmatherapy specialist
Ichor operates in specialized plasmatherapy segment manufacturing therapeutic proteins for neurology, oncology, and organ transplantation
Key stakeholders
Promoters Ananda Reddy Sudini and Sujana Sudini hold 50.5% and 44.5% stakes respectively with Time Cap Pharma Labs holding 5%
Funding strategy
Alvarez & Marsal managing fundraising process with existing backers including UK's Artian Investments and FPrime Capital
Market growth
India's plasma protein therapy market forecast to reach $500 million by 2030 growing at 4% annually
Recent expansion
Ichor expanded plasma processing capacity to 281,000 liters from 130,000 liters by investing 165.33 crore in FY24
What matters most
Ichor Biologics needs $80-100 million from private equity to scale its plasma therapy production capacity
